T.J. Sharpe’s story brings home the reality that the average time to complete a clinical trial agreement (CTA) between sponsors, contract research organizations (CROs) and sites is more than 13 weeks globally and over 10 weeks in North America. These statistics have gotten dramatically worse since 2010. (KMR Group, 2016)
T.J. was diagnosed with Stage IV melanoma in August 2012 at the age of 37, with a wife and two young children at home. He found hope in a clinical trial, however, that hope dimmed when the start of the clinical trial was delayed for six weeks due to a CTA not being executed.
Find out more about what SCRS is doing to reduce CTA negotiation time by downloading a complimentary white paper about the contract clauses developed by the Common Language Evaluation and Reconciliation (CLEAR) working group: https://myscrs.wpenginepowered.com/shop/clear-white-paper/